Design and Efficient Synthesis of Novel 4,5-Dimethylthiazole-Hydrazone Derivatives and their Anticancer Activity

被引:6
作者
Evren, Asaf Evrim [1 ,2 ]
Yurttas, Leyla [1 ]
Ekselli, Busra [3 ]
Aksoy, Onur [3 ]
Akalin-Ciftci, Gulsen [3 ]
机构
[1] Anadolu Univ, Fac Pharm, Dept Pharmaceut Chem, Eskisehir, Turkey
[2] Bilecik Seyh Edebali Univ, Vocat Sch Hlth Serv, Pharm Serv, Bilecik, Turkey
[3] Anadolu Univ, Fac Pharm, Dept Biochem, Eskisehir, Turkey
关键词
Thiazole; hydrazone; A549; C6; apoptosis; anticancer activity; BIOLOGICAL EVALUATION; THIAZOLE DERIVATIVES; LUNG-CANCER; PYRIDINE-DERIVATIVES; DRUG-RESISTANCE; IN-SILICO; CYTOTOXICITY; DASATINIB; ANALOGS; GLIOMA;
D O I
10.2174/1570180817999201022192937
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Background: Recently, researchers have been warning about the increased mortality of the various cancer types. Also, the lung adenocarcinoma and the glioma types are burning issues for world's health due to late or wrong diagnosis and/or insufficient treatment methods. For this purpose, our research group designed and synthesized novel 4,5-dimethyl thiazole-hydrazone derivatives which were tested against cancer and normal cell lines to understand the structure-activity relationship (SAR). Methods: The lead compounds were obtained by reacting 2-(substituted aryl-2-ylmethylene) hydrazin-1-carbothioamide with 3-chloro-2-butanone derivatives. The structural elucidation of the compounds was performed by H-1-NMR, C-13-NMR, and LC/MS-IT-TOF spectral and elemental analyses. The synthesized compounds were tested in vitro for the anticancer activity against A549 human lung adenocarcinoma and C6 rat glioma cells and investigated for which pathway to induce cell death. Also, the docking study of the active compounds was achieved to understand the SAR. Results: The targeted compounds (2a-21) were synthesized successfully above 70% yields, and the analysis findings proved their purity. In general, the results of activity studies displayed significant effects against at least one cell line, except compounds 2e (indol-3-yl) and 2h (4-dimethylaminophenyl). Furthermore, compounds 2b and 2f displayed potential anticancer activity. With the help of molecular docking study, a potential selectivity of compound 2f was observed for type II protein kinase. On the other hand, compound 2b interacted with the active site nearly the same as Dasatinib. Therefore, these two compounds could be used as a base on developing selective anticancer drugs. Conclusion: Pyridin-2-yl (2b) derivative was found to be a favorable molecule with high anticancer potency against C6 and A549 cell lines. Additionally, 1-naphthyl (2f) derivative was a worthy compound for potential selectivity. In future studies, it will be our priority to focus on developing derivatives of these two compounds (2b and 2f) and elucidate their mechanisms.
引用
收藏
页码:372 / 386
页数:15
相关论文
共 76 条
[1]   Potent anticancer and antimicrobial activities of pyrazole, oxazole and pyridine derivatives containing 1,2,4-triazine moiety [J].
Abd El-All, Amira S. ;
Osman, Souad A. ;
Roaiah, Hanaa M. F. ;
Abdalla, Mohamed M. ;
Abd El Aty, Abeer A. ;
AbdEl-Hady, Wafaa H. .
MEDICINAL CHEMISTRY RESEARCH, 2015, 24 (12) :4093-4104
[2]   Synthesis and biological evaluation of some 2,4,5-trisubstituted thiazole derivatives as potential antimicrobial and anticancer agents [J].
Al-Saadi, Mohammed S. ;
Faidallah, Hassan M. ;
Rostom, Sherif A. F. .
ARCHIV DER PHARMAZIE, 2008, 341 (07) :424-434
[3]  
ALBUQUERQUE JFC, 1995, PHARMAZIE, V50, P387
[4]   Design, synthesis, in vitro and in silico evaluation of a new series of oxadiazole-based anticancer agents as potential Akt and FAK inhibitors [J].
Altintop, Mehlika Dilek ;
Sever, Belgin ;
Ciftci, Giilsen Akalin ;
Turan-Zitouni, Gulhan ;
Kaplancikli, Zafer Asim ;
Ozdemir, Ahmet .
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2018, 155 :905-924
[5]   SOME HETEROCYCLIC THIOSEMICARBAZONES [J].
ANDERSON, FE ;
DUCA, CJ ;
SCUDI, JV .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1951, 73 (10) :4967-4968
[6]   Thiazolidine-2,4-diones as multi-targeted scaffold in medicinal chemistry: Potential anticancer agents [J].
Asati, Vivek ;
Mahapatra, Debarshi Kar ;
Bharti, Sanjay K. .
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2014, 87 :814-833
[7]   MTT assay to evaluate the cytotoxic potential of a drug [J].
Bahuguna, Ashutosh ;
Khan, Imran ;
Bajpai, Vivek K. ;
Kang, Sun Chul .
BANGLADESH JOURNAL OF PHARMACOLOGY, 2017, 12 (02) :115-118
[8]   A phase I trial of the MEK inhibitor selumetinib (AZD6244) in pediatric patients with recurrent or refractory low-grade glioma: a Pediatric Brain Tumor Consortium (PBTC) study [J].
Banerjee, Anuradha ;
Jakacki, Regina I. ;
Onar-Thomas, Arzu ;
Wu, Shengjie ;
Nicolaides, Theodore ;
Poussaint, Tina Young ;
Fangusaro, Jason ;
Phillips, Joanna ;
Perry, Arie ;
Turner, David ;
Prados, Michael ;
Packer, Roger J. ;
Qaddoumi, Ibrahim ;
Gururangan, Sridharan ;
Pollack, Ian F. ;
Goldman, Stewart ;
Doyle, Lawrence A. ;
Stewart, Clinton F. ;
Boyett, James M. ;
Kun, Larry E. ;
Fouladi, Maryam .
NEURO-ONCOLOGY, 2017, 19 (08) :1135-1144
[9]   THE CHEMOTHERAPY OF EXPERIMENTAL TUBERCULOSIS .3. THE SYNTHESIS OF THIOSEMICARBAZONES AND RELATED COMPOUNDS [J].
BERNSTEIN, J ;
YALE, HL ;
LOSEE, K ;
HOLSING, M ;
MARTINS, J ;
LOTT, WA .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1951, 73 (03) :906-912
[10]   Phase I Trial, Pharmacokinetics, and Pharmacodynamics of Vandetanib and Dasatinib in Children with Newly Diagnosed Diffuse Intrinsic Pontine Glioma [J].
Broniscer, Alberto ;
Baker, Sharyn D. ;
Wetmore, Cynthia ;
Panandiker, Atmaram S. Pai ;
Huang, Jie ;
Davidoff, Andrew M. ;
Onar-Thomas, Arzu ;
Panetta, John C. ;
Chin, Thomas K. ;
Merchant, Thomas E. ;
Baker, Justin N. ;
Kaste, Sue C. ;
Gajjar, Amar ;
Stewart, Clinton F. .
CLINICAL CANCER RESEARCH, 2013, 19 (11) :3050-3058